<DOC>
	<DOCNO>NCT01935674</DOCNO>
	<brief_summary>To compare effect rosuvastatin protease inhibitor switch fast total cholesterol 12 week .</brief_summary>
	<brief_title>Treatment With Rosuvastatin Versus Switching PI ( Protease Inhibitor ) Patients HIV With High Cholesterol Levels</brief_title>
	<detailed_description>To compare effect rosuvastatin protease inhibitor switching : - Total cholesterol week 12 - Safety parameter ( HIV viral load , clinical adverse event , serious adverse event , laboratory adverse event , modification antiretroviral therapy ) - Quality life ( SF-12 ) - Fasting LDL cholesterol ( estimate Friedewald equation unless triglyceride &gt; 400mg/dL , case LDL-C would measure directly ) , HDL cholesterol , total : HDL cholesterol ratio , LDL particles size , triglyceride - Fasting glucose insulin - Framingham cardiovascular risk score - D : A : D 5-year estimate risk calculator</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<criteria>HIVpositive status Adults ( ≥18 year age ) Stable welltolerated combination ART include ritonavirboosted protease inhibitor previous 6 month HIV RNA &lt; 50 copies/mL least precede 3 month Fasting total cholesterol ≥5.5 mmol/L ( &gt; 213 mg/dL ) Framingham risk score ≥8 % 10 year OR diabetes mellitus OR family history premature coronary artery disease firstdegree relative Provision write , informed consent Exclusion criterion : Any statin previous 12 week Previous statininduced myopathy hepatitis History coronary artery disease , stroke indication use statin therapy ( hyperlipidaemia : genetic , secondary idiopathic ) Concurrent use : 1. oral corticosteroid use replacement therapy ( i.e . prednisolone 57.5 mg , hydrocortisone 2030 mg , cortisone acetate 2537.5 mg daily ) 2. immunosuppressive immunomodulating drug Contraindication rosuvastatin therapy : 1. liver transaminase &gt; 5 time upper normal limit 2. creatinine clearance &lt; 30 mL/min 3. know myopathy 4. current fibrate therapy 5. know resistance one `` backbone '' ART drug No potent switch ART drug available replace current ritonavirboosted protease inhibitor Known intolerance rosuvastatin propose switch ART drug Women attempt likely become pregnant , pregnant breastfeed A patient history current evidence condition , therapy , laboratory abnormality , circumstance might confound result study , interfere patient 's participation full duration study Unable complete study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Hypercholesterolaemia</keyword>
	<keyword>HIV</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>Protease inhibitor switch</keyword>
</DOC>